|
End-of-day quote
Bulgaria S.E.
11/11/2026
|
5-day change | 1st Jan Change | ||
| 3.260 EUR | -1.21% |
|
-1.51% | +128.84% |
| 21/09 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended August 2026 | CI |
| 28/08 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 324.24Cr 194.74Cr 175.52Cr 162.16Cr 146.59Cr 277.34Cr 18TCr 284.19Cr 1.94TCr 774.58Cr 9.78TCr 730.86Cr 715.32Cr 31TCr | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 378.37Cr 227.25Cr 204.82Cr 189.23Cr 171.06Cr 323.64Cr 21TCr 331.63Cr 2.27TCr 903.89Cr 11TCr 852.87Cr 834.73Cr 36TCr | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | -1.21% | ||
| 1 week | -1.51% | ||
| Current month | -2.98% | ||
| 1 month | +24.43% | ||
| 3 months | +70.68% | ||
| 6 months | +74.80% | ||
| Current year | +128.84% |
| 1 week | 3.23 |  | 3.39 |
| 1 month | 2.58 | | 3.56 |
| Current year | 1.41 | | 3.56 |
| 1 year | 1.34 | | 3.56 |
| 3 years | 0.94 | | 3.56 |
| 5 years | 0.68 | | 3.56 |
| 10 years | 0.41 | | 3.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 30/09/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 29/09/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.21% | -1.51% | +136.15% | +166.39% | 198.12Cr | |
| -2.05% | +4.53% | -31.72% | +11.30% | 1.74TCr | |
| -1.74% | +7.86% | -10.30% | +13.16% | 714.41Cr | |
| -2.10% | +2.33% | -9.37% | +4.82% | 679.13Cr | |
| -1.96% | +1.35% | -48.36% | -36.55% | 629.5Cr | |
| -20.27% | -5.25% | -34.84% | -43.88% | 454.71Cr | |
| -0.04% | -10.31% | -0.08% | -22.32% | 445.09Cr | |
| -0.59% | -3.63% | +8.10% | -20.63% | 345.66Cr | |
| -1.03% | +2.48% | -23.77% | +31.39% | 318.51Cr | |
| -1.28% | +3.90% | -17.62% | -19.85% | 315.28Cr | |
| Average | -3.23% | +1.94% | -3.18% | +8.38% | 584Cr | |
| Weighted average by Cap. | -3.06% | +3.61% | -16.88% | +1.55% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 213.95Cr 128.5Cr 115.81Cr 107Cr 97Cr 183Cr 12TCr 187.52Cr 1.28TCr 511.1Cr 6.45TCr 482.25Cr 471.99Cr 21TCr | 263.27Cr 158.12Cr 142.51Cr 131.66Cr 119.03Cr 225.18Cr 15TCr 230.74Cr 1.58TCr 628.92Cr 7.94TCr 593.42Cr 580.8Cr 25TCr |
| Net income | 7.78Cr 4.68Cr 4.21Cr 3.89Cr 3.52Cr 6.66Cr 438.51Cr 6.82Cr 47Cr 19Cr 234.85Cr 18Cr 17Cr 747.38Cr | 13Cr 8.02Cr 7.23Cr 6.68Cr 6.04Cr 11Cr 752.14Cr 12Cr 80Cr 32Cr 402.82Cr 30Cr 29Cr 1.28TCr |
| Net Debt | 44Cr 27Cr 24Cr 22Cr 20Cr 38Cr 2.5TCr 39Cr 266.23Cr 106.11Cr 1.34TCr 100.12Cr 98Cr 4.26TCr | 54Cr 33Cr 29Cr 27Cr 24Cr 46Cr 3.05TCr 47Cr 324.42Cr 129.3Cr 1.63TCr 122Cr 119.41Cr 5.2TCr |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | €3.260 | -1.21% | 3,931 |
| 10/26/10 | €3.300 | +1.54% | 14,406 |
| 09/26/09 | €3.250 | -2.40% | 20,721 |
| 06/26/06 | €3.330 | +0.91% | 16,302 |
| 05/26/05 | €3.300 | +0.92% | 10,111 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
